Autor | Sousa, Luciana P. | |
Autor | Mariuba, Luis Andre | |
Autor | Holanda, Rudson J. | |
Autor | Pimentel, Juliana P. | |
Autor | Almeida, Maria E. | |
Autor | Chaves, Yuri O. | |
Autor | Borges, Davi | |
Autor | Lima, Emerson | |
Autor | Crainey, James Lee | |
Autor | Orlandi, Patricia P. | |
Autor | Lacerda, Marcus Vinicius | |
Autor | Nogueira, Paulo Afonso | |
Data de acesso | 2017-09-06T16:49:31Z | |
Data de disponibilização | 2017-09-06T16:49:31Z | |
Data do publicação | 2014 | |
Citação | http://www.biomedcentral.com/1471-2334/14/49 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/20925 | |
Descrição | The authors thank the Program for Technological Development in Tools for
Health-PDTIS/FIOCRUZ for use of its facilities, and for financial support provided
by CNPq – “Conselho Nacional de desenvolvimento científico e tecnológico”
and FAPEAM – “Fundação de Amparo a pesquisa do Amazonas”. | pt_BR |
Idioma | eng | pt_BR |
Editor | Biomed Central | pt_BR |
Direito Autoral | open access | pt_BR |
Palavras-chave | Diagnostico da Malaria | pt_BR |
Palavras-chave | Elisa | pt_BR |
Palavras-chave | Proteina Recombinante | pt_BR |
Título | A novel polyclonal antibody-based sandwich ELISA for detection of Plasmodium vivax developed from two lactate dehydrogenase protein segments. | pt_BR |
Tipo do documento | Article | pt_BR |
Resumo em Inglês | Abstract
Background: Immunoassays for Plasmodium detection are, presently, most frequently based on monoclonal
antibodies (MAbs); Polyclonal antibodies (PAbs), which are cheaper to develop and manufacture, are much less
frequently used. In the present study we describe a sandwich ELISA assay which is capable of detecting P. vivax Lactate
Dehydrogenase (LDH) in clinical blood samples, without cross reacting with those infected with P. falciparum.
Methods: Two recombinant proteins were produced from different regions of the P. vivax LDH gene. Two sandwich
ELISA assay were then designed: One which uses mouse anti-LDH 1-43aa PAbs as primary antibodies (“Test 1”) and
another which uses anti-LDH 35-305aa PAbs (“Test 2”) as the primary antibodies. Rabbit anti-LDH 1-43aa PAbs were
used as capture antibodies in both ELISA assays. Blood samples taken from P. vivax and P. falciparum infected patients
(confirmed by light microscopy) were analysed using both tests.
Results: “Test 2” performed better at detecting microscopy-positive blood samples when compared to “Test 1”,
identifying 131 of 154 positive samples (85%); 85 positives (55%) were identified using “test 1”. “Test 1” produced
one false positive sample (from the 20 malaria-free control) blood samples; “test 2” produced none. Kappa coefficient
analysis of the results produced a value of 0.267 when microscope-positive blood smears were compared with “test 1”,
but 0.734 when microscope-positive blood smears were compared with the results from “test 2”. Positive predictive
value (PPV) and negative predictive value (NPV) were observed to be 98% and 22% respectively, for “Test 1”, and 99%
and 45%, for “test 2”. No cross reactivity was detected with P. falciparum positive blood samples (n = 15) with either test
assay.
Conclusion: Both tests detected P. vivax infected blood and showed no evidence of cross-reacting with P. falciparum.
Further studies will need to be conducted to establish the full potential of this technique for malaria diagnostics. As
well as representing a promising new cost-effective novel technique for P. vivax diagnosis and research, the method
for developing this assay also highlights the potential for PAb-based strategies for diagnostics in general. | pt_BR |
Afiliação | Instituto Leônidas e Maria Deane | pt_BR |
Afiliação | Universidade Federal do Amazonas | pt_BR |
Afiliação | Fundação de Medicina Tropical Heitor Vieira Dourado | pt_BR |
Palavras-chave em inglês | Malaria diagnosis | pt_BR |
Palavras-chave em inglês | Recombinant protein | pt_BR |
Palavras-chave em inglês | Elisa | pt_BR |
Data de embargo | 2015-03-19 | |